Efficacy News and Research

RSS
Damon Runyon Cancer Research Foundation names 18 new Fellows

Damon Runyon Cancer Research Foundation names 18 new Fellows

Foundation Medicine, Sanofi enter strategic collaboration for cancer genome analysis

Foundation Medicine, Sanofi enter strategic collaboration for cancer genome analysis

Third-party to prepare FDA submittals for NanoLogix

Third-party to prepare FDA submittals for NanoLogix

Pulmonx receives CE approval for expanded labeling of Zephyr endobronchial valve

Pulmonx receives CE approval for expanded labeling of Zephyr endobronchial valve

ADHD diet: Review of studies

ADHD diet: Review of studies

Questions raised over nicotine replacement therapy: Study

Questions raised over nicotine replacement therapy: Study

Study demonstrates that individuals can eat out and still lose weight

Study demonstrates that individuals can eat out and still lose weight

QIAGEN's therascreen EGFR Mutation Detection Kit receives Japanese regulatory approval

QIAGEN's therascreen EGFR Mutation Detection Kit receives Japanese regulatory approval

Combination of GXR and psychostimulant safe and effective for children with ADHD

Combination of GXR and psychostimulant safe and effective for children with ADHD

Oxygen Biotherapeutics to commence study to determine efficacy of Dermacyte in relieving Histamine induced pruritus

Oxygen Biotherapeutics to commence study to determine efficacy of Dermacyte in relieving Histamine induced pruritus

Cameron Health's PMA application for S-ICD System submitted to FDA

Cameron Health's PMA application for S-ICD System submitted to FDA

Progress report on commercialization of BENLYSTA to be announced at JPMorgan Healthcare Conference

Progress report on commercialization of BENLYSTA to be announced at JPMorgan Healthcare Conference

Presidio completes PPI-668 Phase 1a study on hepatitis C

Presidio completes PPI-668 Phase 1a study on hepatitis C

Pfizer, SFJ to conduct axitinib Phase 3 trial in renal cell carcinoma

Pfizer, SFJ to conduct axitinib Phase 3 trial in renal cell carcinoma

JDRF, KalVista collaborate to focus on novel approach for diabetic macular edema

JDRF, KalVista collaborate to focus on novel approach for diabetic macular edema

Enrollment complete in Diamyd Phase II study for type 1 diabetes

Enrollment complete in Diamyd Phase II study for type 1 diabetes

Colby's JVRS-100 enhances immunogenicity, cross-protective efficacy of H5N1 influenza vaccine

Colby's JVRS-100 enhances immunogenicity, cross-protective efficacy of H5N1 influenza vaccine

miRagen, Silence partner to assess delivery potential of novel miRNA-based therapeutics

miRagen, Silence partner to assess delivery potential of novel miRNA-based therapeutics

MPIIB, QIAGEN partner to develop latent TB diagnostic test

MPIIB, QIAGEN partner to develop latent TB diagnostic test

AICAR therapy may combat heat stroke

AICAR therapy may combat heat stroke

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.